EXACT SCIENCES CORP Insider Trading Activity
Every SEC Form 4 insider transaction reported for EXACT SCIENCES CORP (EXAS), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are EXAS insiders buying or selling?
In the last 12 months, EXACT SCIENCES CORP insiders reported 0 open-market purchases ($0) and 5 sales ($1.5M) — net selling of $1.5M. Since January 2018, Trabud has recorded 256 Form 4 filings for EXAS: 1 buys ($1.0M) and 255 sells ($249.6M).
Source: SEC EDGAR Form 4
What stands out
- No EXACT SCIENCES CORP insider made an open-market purchase in the last 12 months; the 5 reported open-market sales totaled $1.5M.
Key Statistics (January 2018 – Nov 21, 2025)
Total Form 4 filings
256
SEC EDGAR
Insider filers
20
Insider buys (1)
$1.0M
Insider sells (255)
$249.6M
Insider sentiment
Net sellingNet insider flow of $248.6M in net selling since January 2018, and $1.5M in net selling over the last 12 months.
Recent EXAS insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Jacob A Orville | EVP, GM, Screening | Sale | 5.0K | $75.00 | $375.0K | SEC ↗ |
| Nov 21, 2025 | James Herriott | SVP, General Counsel & Sec | Sale | 1.0K | $70.00 | $70.0K | SEC ↗ |
| Nov 6, 2025 | James Herriott | SVP, General Counsel & Sec | Sale | 1.5K | $70.08 | $105.1K | SEC ↗ |
| Nov 6, 2025 | Brian Baranick | EVP, GM, Precision Oncology | Sale | 2.9K | $70.08 | $200.3K | SEC ↗ |
| Oct 28, 2025 | Katherine S Zanotti | Director | Sale | 12.0K | $65.00 | $780.0K | SEC ↗ |
| Oct 10, 2025 | James Herriott | SVP, General Counsel & Sec | Sale | 1.5K | $60.00 | $90.0K | SEC ↗ |
| Oct 10, 2025 | James Edward Doyle | Director | Sale | 2.0K | $60.00 | $120.0K | SEC ↗ |
| Jun 16, 2025 | Katherine S Zanotti | Director | Sale | 3.2K | $53.20 | $170.6K | SEC ↗ |
| Nov 13, 2024 | Kevin T Conroy | President and CEO | Purchase | 19.5K | $51.35 | $1.0M | SEC ↗ |
| Oct 9, 2024 | Brian Baranick | EVP, GM, Precision Oncology | Sale | 929 | $70.00 | $65.0K | SEC ↗ |
| Sep 19, 2024 | Brian Baranick | EVP, GM, Precision Oncology | Sale | 929 | $70.00 | $65.0K | SEC ↗ |
| May 2, 2024 | Scott D Coward | Director | Sale | 67 | $60.15 | $4.0K | SEC ↗ |
| May 2, 2024 | Everett Cunningham | Chief Commercial Officer | Sale | 136 | $60.15 | $8.2K | SEC ↗ |
| May 2, 2024 | James Herriott | SVP, General Counsel & Sec | Sale | 30 | $60.15 | $1.8K | SEC ↗ |
| May 2, 2024 | Jeffrey Thomas Elliott | Chief Financial Officer | Sale | 136 | $60.15 | $8.2K | SEC ↗ |
| May 2, 2024 | Brian Baranick | EVP, GM., Precision Oncology | Sale | 110 | $60.15 | $6.6K | SEC ↗ |
| May 2, 2024 | Sarah Condella | EVP, Human Resources | Sale | 102 | $60.15 | $6.1K | SEC ↗ |
| May 2, 2024 | Jacob A Orville | General Manager, Screening | Sale | 102 | $60.15 | $6.1K | SEC ↗ |
| May 2, 2024 | Kevin T Conroy | President and CEO | Sale | 1.2K | $60.15 | $69.5K | SEC ↗ |
| Apr 3, 2024 | Sarah Condella | EVP, Human Resources | Sale | 2.0K | $70.00 | $140.0K | SEC ↗ |
| Apr 3, 2024 | Brian Baranick | EVP, GM., Precision Oncology | Sale | 924 | $79.43 | $73.4K | SEC ↗ |
| Mar 5, 2024 | Jacob A Orville | General Manager, Screening | Sale | 2.2K | $59.32 | $127.8K | SEC ↗ |
| Mar 5, 2024 | Daniel J Levangie | Director | Sale | 5.0K | $57.50 | $287.5K | SEC ↗ |
| Mar 5, 2024 | James Herriott | General Counsel | Sale | 862 | $59.32 | $51.1K | SEC ↗ |
| Mar 5, 2024 | Jeffrey Thomas Elliott | Chief Financial Officer | Sale | 2.4K | $59.32 | $143.1K | SEC ↗ |
Showing the 25 most recent of 256 Form 4 filings for EXACT SCIENCES CORP.
Most active EXAS insiders
- Kevin T Conroy47 filings
- Jeffrey Thomas Elliott30 filings
- Scott D Coward29 filings
- Sarah Condella28 filings
- Jacob A Orville18 filings
Ask anything about EXAS insider activity
Use Trabud's AI agent to query EXACT SCIENCES CORP's Form 4 history in plain English — "Show me EXAS CEO purchases this year" or compare it against any other ticker.
Open the AI agentEXAS insider trading FAQ
Are EXACT SCIENCES CORP insiders buying or selling?
In the last 12 months, EXACT SCIENCES CORP insiders reported 0 open-market purchases ($0) and 5 sales ($1.5M) — net selling of $1.5M. Since January 2018, Trabud has recorded 256 Form 4 filings for EXAS: 1 buys ($1.0M) and 255 sells ($249.6M). Over the full record that is net selling of $248.6M.
How many insiders trade EXAS stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for EXACT SCIENCES CORP. The most recent filing was accepted on Nov 21, 2025.
Where does Trabud get EXAS insider trading data?
All EXAS insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.